Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
462.14
-7.62 (-1.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
52
53
Next >
3 No-Brainer Stocks to Buy in a New Bull Market
April 08, 2023
These stocks have what it takes to soar if and when a new bull market begins.
Via
The Motley Fool
CRISPR Stock: Bull vs. Bear
April 08, 2023
CRISPR's first approved product may be right around the corner.
Via
The Motley Fool
Nasdaq Bear Market: 5 Astonishing Growth Stocks You'll Regret Not Buying on the Dip
April 08, 2023
A 33% plunge in the Nasdaq Composite is the perfect excuse for opportunistic investors to pounce on discounted growth stocks.
Via
The Motley Fool
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
April 07, 2023
Medical stocks are holding up amid economic and market uncertainty.
Via
Investor's Business Daily
2 Once-in-a-Decade Buying Opportunities in a Growth Stock Bear Market
April 07, 2023
These stocks have growth stories that investors might find too compelling to overlook.
Via
The Motley Fool
A Bull Market Is Coming: 2 Unstoppable Growth Stocks to Scoop Up Right Now
April 07, 2023
Don't let these superior stocks pass you by.
Via
The Motley Fool
Why Bluebird Bio Shares Are Plunging Today
March 29, 2023
Via
Benzinga
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
March 28, 2023
Via
Benzinga
2 Smartest Growth Stocks to Buy Without Hesitation Right Now
April 06, 2023
A turbulent market is still full of opportunity for shrewd investors.
Via
The Motley Fool
Where to Invest $2,500 Right Now
April 06, 2023
Even another bear market doesn't need to deter investors with the appropriate buy-and-hold horizon.
Via
The Motley Fool
2 Top Stocks to Buy Before the Next Nasdaq Bull Market
April 06, 2023
Tough market conditions will eventually give way to the next bull run on stocks.
Via
The Motley Fool
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
April 06, 2023
Via
Benzinga
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
April 04, 2023
Vertex shares are on the rise.
Via
The Motley Fool
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags
April 03, 2023
It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners.
Via
Talk Markets
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years
April 03, 2023
Via
Benzinga
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
April 03, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
A Nasdaq Bull Market Could Begin in April: 3 Top Stocks to Buy Now
April 02, 2023
The momentum for these stocks should accelerate when a Nasdaq bull market begins.
Via
The Motley Fool
5 Top Stocks for April
April 02, 2023
From growth stocks to dividend stocks, there are plenty of buying opportunities this spring.
Via
The Motley Fool
The 10 Best Stocks to Buy in April 2023
April 01, 2023
Here are 10 stocks to buy now that could unlock explosive gains in your growth-stock portfolio.
Via
The Motley Fool
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics
April 01, 2023
Together, the companies could produce a game-changing product.
Via
The Motley Fool
This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market. Here's What It Means for Investors
March 31, 2023
It wouldn't be the first time the company finds success in a lucrative area.
Via
The Motley Fool
Have $2,000? 2 Exceptional Stocks to Buy In a Bear Market
March 31, 2023
The current market is challenging investors' fortitude, but patience can pay off.
Via
The Motley Fool
BioMarin Pharmaceutical Stock Shows Rising Relative Strength
March 30, 2023
BioMarin Pharmaceutical stock had its Relative Strength Rating upgraded to 77 on Thursday, up from 70 a day earlier.
Via
Investor's Business Daily
What Bear Market? These 2 Winning Stocks Are Still Worth Buying.
March 30, 2023
These two pharma stocks are rock-solid picks in any kind of market.
Via
The Motley Fool
2 Top Stocks to Buy With $1,000 Right Now
March 30, 2023
These growth-oriented businesses are marking wins even in a challenging environment.
Via
The Motley Fool
2 No-Brainer Stocks to Buy Before the Next Bull Market
March 30, 2023
These stocks each have superior businesses that can reward investors over the long haul.
Via
The Motley Fool
2 No-Brainer Growth Stocks to Buy and Hold for Years
March 30, 2023
A long-term investment in these highly profitable businesses could pay off in manifold returns over the next 5 to 10 years.
Via
The Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
March 29, 2023
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors.
Via
InvestorPlace
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
March 29, 2023
These stocks look reasonably priced considering their future prospects.
Via
The Motley Fool
Alkermes Stock Sees Rising Relative Strength Rating
March 28, 2023
The Relative Strength (RS) Rating for Alkermes stock climbed into a new percentile Tuesday, as it got a lift from 69 to 77.
Via
Investor's Business Daily
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
52
53
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.